louisiana semaglutide ileus class action Diabetes Drugs & Gastrointestinal Injuries The FDA sent a warning

Until robust Phase 3 trial results are available, injectables and oral formulations remain the evidence-based standard for GLP-1 therapy initiation

Each syringe is filled with your designated dose and should be kept in the fridge until its ready to be used

Glucagon receptor agonism: Increases energy expenditure and promotes fat oxidation, contributing to weight reduction

For your convenience, Portner & Shure, P.A

The results showed that the GLP-1RA group experienced a significant total body weight loss of 7.87% in one year, compared to 4.24% in the non-GLP-1RA group

Both forms are HSA and FSA eligible, reducing out-of-pocket costs further for eligible patients